Selected research
Market Structure
Global Laboratory Developed Tests (LDT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Laboratory Developed Tests (LDT) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Laboratory Developed Tests (LDT) include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Laboratory Developed Tests (LDT) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Laboratory Developed Tests (LDT) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Laboratory Developed Tests (LDT) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Laboratory Developed Tests (LDT) market size, projected growth trends, production technologies, key applications, and end-use industries.
Laboratory Developed Tests (LDT) Segment by Company
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Adaptive Biotechnologies
Biodesix
Berry Oncology
Genetron Health
Laboratory Developed Tests (LDT) Segment by Type
Clinical Biochemistry
Hematology
Immunology
Molecular Diagnostics
Other
Laboratory Developed Tests (LDT) Segment by Application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Other
Laboratory Developed Tests (LDT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Developed Tests (LDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory Developed Tests (LDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Developed Tests (LDT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Laboratory Developed Tests (LDT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory Developed Tests (LDT) industry.
Chapter 3: Detailed analysis of Laboratory Developed Tests (LDT) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Laboratory Developed Tests (LDT)revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Clinical Biochemistry
- Hematology
- Immunology
- Molecular Diagnostics
- Other
Applications
- Hospitals Laboratory
- Clinical Research Organizations
- Academic Institutes
- Specialty Diagnostic Centers
- Other
Companies covered
- Quest Diagnostics
- Thermo Fisher
- Waters Corporation
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Adaptive Biotechnologies
- Biodesix
- Berry Oncology
- Genetron Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Clinical Biochemistry
- 1.2.3 Hematology
- 1.2.4 Immunology
- 1.2.5 Molecular Diagnostics
- 1.2.6 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals Laboratory
- 1.3.3 Clinical Research Organizations
- 1.3.4 Academic Institutes
- 1.3.5 Specialty Diagnostic Centers
- 1.3.6 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Laboratory Developed Tests (LDT) Growth Trends by Region
- 1.5.1 Global Laboratory Developed Tests (LDT) Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Laboratory Developed Tests (LDT) Market Size by Region (2021-2026)
- 1.5.3 Laboratory Developed Tests (LDT) Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Laboratory Developed Tests (LDT) Market Dynamics
- 2.1 Laboratory Developed Tests (LDT) Industry Trends
- 2.2 Laboratory Developed Tests (LDT) Industry Drivers
- 2.3 Laboratory Developed Tests (LDT) Industry Opportunities and Challenges
- 2.4 Laboratory Developed Tests (LDT) Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Laboratory Developed Tests (LDT) Revenue by Company (2021-2026)
- 3.2 Global Laboratory Developed Tests (LDT) Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Laboratory Developed Tests (LDT) Key Company Head office and Area Served
- 3.4 Global Laboratory Developed Tests (LDT) Company, Product Type & Application
- 3.5 Global Laboratory Developed Tests (LDT) Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Laboratory Developed Tests (LDT) Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Laboratory Developed Tests (LDT) Players Market Share by Revenue in 2025
- 3.6.3 2025 Laboratory Developed Tests (LDT) Tier 1, Tier 2, and Tier 3
4 Laboratory Developed Tests (LDT) Market by Type
- 4.1 Global Laboratory Developed Tests (LDT) Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Laboratory Developed Tests (LDT) Market Size by Type (2021-2032)
- 4.3 Global Laboratory Developed Tests (LDT) Market Size Share by Type (2021-2032)
5 Laboratory Developed Tests (LDT) Market by Application
- 5.1 Global Laboratory Developed Tests (LDT) Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Laboratory Developed Tests (LDT) Market Size by Application (2021-2032)
- 5.3 Global Laboratory Developed Tests (LDT) Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Quest Diagnostics
- 6.1.1 Quest Diagnostics Company Information
- 6.1.2 Quest Diagnostics Business Overview
- 6.1.3 Quest Diagnostics Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio
- 6.1.5 Quest Diagnostics Recent Developments
- 6.2 Thermo Fisher
- 6.2.1 Thermo Fisher Company Information
- 6.2.2 Thermo Fisher Business Overview
- 6.2.3 Thermo Fisher Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio
- 6.2.5 Thermo Fisher Recent Developments
- 6.3 Waters Corporation
- 6.3.1 Waters Corporation Company Information
- 6.3.2 Waters Corporation Business Overview
- 6.3.3 Waters Corporation Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio
- 6.3.5 Waters Corporation Recent Developments
- 6.4 Roche
- 6.4.1 Roche Company Information
- 6.4.2 Roche Business Overview
- 6.4.3 Roche Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Roche Laboratory Developed Tests (LDT) Product Portfolio
- 6.4.5 Roche Recent Developments
- 6.5 Illumina
- 6.5.1 Illumina Company Information
- 6.5.2 Illumina Business Overview
- 6.5.3 Illumina Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Illumina Laboratory Developed Tests (LDT) Product Portfolio
- 6.5.5 Illumina Recent Developments
- 6.6 Qiagen
- 6.6.1 Qiagen Company Information
- 6.6.2 Qiagen Business Overview
- 6.6.3 Qiagen Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Qiagen Laboratory Developed Tests (LDT) Product Portfolio
- 6.6.5 Qiagen Recent Developments
- 6.7 Eurofins
- 6.7.1 Eurofins Company Information
- 6.7.2 Eurofins Business Overview
- 6.7.3 Eurofins Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Eurofins Laboratory Developed Tests (LDT) Product Portfolio
- 6.7.5 Eurofins Recent Developments
- 6.8 Guardant Health
- 6.8.1 Guardant Health Company Information
- 6.8.2 Guardant Health Business Overview
- 6.8.3 Guardant Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Guardant Health Laboratory Developed Tests (LDT) Product Portfolio
- 6.8.5 Guardant Health Recent Developments
- 6.9 Adaptive Biotechnologies
- 6.9.1 Adaptive Biotechnologies Company Information
- 6.9.2 Adaptive Biotechnologies Business Overview
- 6.9.3 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio
- 6.9.5 Adaptive Biotechnologies Recent Developments
- 6.10 Biodesix
- 6.10.1 Biodesix Company Information
- 6.10.2 Biodesix Business Overview
- 6.10.3 Biodesix Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Biodesix Laboratory Developed Tests (LDT) Product Portfolio
- 6.10.5 Biodesix Recent Developments
- 6.11 Berry Oncology
- 6.11.1 Berry Oncology Company Information
- 6.11.2 Berry Oncology Business Overview
- 6.11.3 Berry Oncology Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio
- 6.11.5 Berry Oncology Recent Developments
- 6.12 Genetron Health
- 6.12.1 Genetron Health Company Information
- 6.12.2 Genetron Health Business Overview
- 6.12.3 Genetron Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Genetron Health Laboratory Developed Tests (LDT) Product Portfolio
- 6.12.5 Genetron Health Recent Developments
7 North America
- 7.1 North America Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 7.2 North America Laboratory Developed Tests (LDT) Market Size by Type
- 7.2.1 North America Laboratory Developed Tests (LDT) Market Size by Type (2021-2026)
- 7.2.2 North America Laboratory Developed Tests (LDT) Market Size by Type (2027-2032)
- 7.2.3 North America Laboratory Developed Tests (LDT) Market Share by Type (2021-2032)
- 7.3 North America Laboratory Developed Tests (LDT) Market Size by Application
- 7.3.1 North America Laboratory Developed Tests (LDT) Market Size by Application (2021-2026)
- 7.3.2 North America Laboratory Developed Tests (LDT) Market Size by Application (2027-2032)
- 7.3.3 North America Laboratory Developed Tests (LDT) Market Share by Application (2021-2032)
- 7.4 North America Laboratory Developed Tests (LDT) Market Size by Country
- 7.4.1 North America Laboratory Developed Tests (LDT) Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 7.4.3 North America Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 7.4.4 North America Laboratory Developed Tests (LDT) Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 8.2 Europe Laboratory Developed Tests (LDT) Market Size by Type
- 8.2.1 Europe Laboratory Developed Tests (LDT) Market Size by Type (2021-2026)
- 8.2.2 Europe Laboratory Developed Tests (LDT) Market Size by Type (2027-2032)
- 8.2.3 Europe Laboratory Developed Tests (LDT) Market Share by Type (2021-2032)
- 8.3 Europe Laboratory Developed Tests (LDT) Market Size by Application
- 8.3.1 Europe Laboratory Developed Tests (LDT) Market Size by Application (2021-2026)
- 8.3.2 Europe Laboratory Developed Tests (LDT) Market Size by Application (2027-2032)
- 8.3.3 Europe Laboratory Developed Tests (LDT) Market Share by Application (2021-2032)
- 8.4 Europe Laboratory Developed Tests (LDT) Market Size by Country
- 8.4.1 Europe Laboratory Developed Tests (LDT) Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 8.4.3 Europe Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 8.4.4 Europe Laboratory Developed Tests (LDT) Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 9.2 China Laboratory Developed Tests (LDT) Market Size by Type
- 9.2.1 China Laboratory Developed Tests (LDT) Market Size by Type (2021-2026)
- 9.2.2 China Laboratory Developed Tests (LDT) Market Size by Type (2027-2032)
- 9.2.3 China Laboratory Developed Tests (LDT) Market Share by Type (2021-2032)
- 9.3 China Laboratory Developed Tests (LDT) Market Size by Application
- 9.3.1 China Laboratory Developed Tests (LDT) Market Size by Application (2021-2026)
- 9.3.2 China Laboratory Developed Tests (LDT) Market Size by Application (2027-2032)
- 9.3.3 China Laboratory Developed Tests (LDT) Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 10.2 Asia Laboratory Developed Tests (LDT) Market Size by Type
- 10.2.1 Asia Laboratory Developed Tests (LDT) Market Size by Type (2021-2026)
- 10.2.2 Asia Laboratory Developed Tests (LDT) Market Size by Type (2027-2032)
- 10.2.3 Asia Laboratory Developed Tests (LDT) Market Share by Type (2021-2032)
- 10.3 Asia Laboratory Developed Tests (LDT) Market Size by Application
- 10.3.1 Asia Laboratory Developed Tests (LDT) Market Size by Application (2021-2026)
- 10.3.2 Asia Laboratory Developed Tests (LDT) Market Size by Application (2027-2032)
- 10.3.3 Asia Laboratory Developed Tests (LDT) Market Share by Application (2021-2032)
- 10.4 Asia Laboratory Developed Tests (LDT) Market Size by Country
- 10.4.1 Asia Laboratory Developed Tests (LDT) Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 10.4.3 Asia Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 10.4.4 Asia Laboratory Developed Tests (LDT) Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Type
- 11.2.1 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Application
- 11.3.1 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country
- 11.4.1 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Laboratory Developed Tests (LDT) Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst